• LAST PRICE
    2.2000
  • TODAY'S CHANGE (%)
    Trending Up0.1200 (5.7692%)
  • Bid / Lots
    2.0800/ 2
  • Ask / Lots
    2.1300/ 17
  • Open / Previous Close
    2.0200 / 2.0800
  • Day Range
    Low 1.8500
    High 2.2400
  • 52 Week Range
    Low 1.2300
    High 35.5000
  • Volume
    477,684
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 2.08
TimeVolumeINM
09:32 ET54151.995
09:33 ET35852
09:35 ET2771.9801
09:37 ET35871.9951
09:39 ET2502.0062
09:42 ET51231.98
09:44 ET508231.8805
09:46 ET270381.94
09:48 ET3001.93
09:50 ET6001.94
09:51 ET1001.96
09:53 ET2001.94
09:57 ET19071.96
10:00 ET10961.9301
10:02 ET11791.9
10:04 ET20001.91
10:06 ET46321.8901
10:08 ET14901.91
10:09 ET34911.9136
10:11 ET145581.8901
10:13 ET3001.8901
10:15 ET44001.92
10:18 ET2001.94
10:20 ET25001.97
10:22 ET1001.97
10:24 ET52382.0405
10:26 ET6002.0699
10:27 ET24152.0699
10:29 ET2502.05
10:33 ET68761.97
10:36 ET30001.9771
10:38 ET3002.0099
10:44 ET6042.01
10:45 ET3671.9801
10:47 ET26112.0099
10:51 ET1002
10:56 ET3232.01
11:00 ET8072
11:02 ET12752
11:05 ET1002.01
11:07 ET3002.01
11:09 ET31002.0176
11:12 ET43122.0599
11:14 ET5002.0699
11:16 ET5002.0697
11:18 ET40002.07
11:21 ET14002.04
11:23 ET7102.0204
11:25 ET5002.04
11:30 ET9002.02
11:39 ET56872
11:41 ET27262.02
11:43 ET29002
11:45 ET40501.9919
11:48 ET10002.02
11:50 ET3801.9931
11:52 ET40591.98
11:59 ET20001.9815
12:01 ET10002.0082
12:03 ET63451.9918
12:06 ET35802
12:08 ET2002.04
12:24 ET5372.01
12:26 ET5002.0101
12:28 ET1002.0101
12:32 ET60592.025
12:33 ET34822.025
12:44 ET30002.0361
12:50 ET6282.0383
12:57 ET43662
01:04 ET66122
01:06 ET43002
01:13 ET49061.9911
01:15 ET1161.9952
01:27 ET11001.9997
01:31 ET1001.99
01:40 ET5761.9865
01:44 ET10001.9816
01:58 ET3632.015
02:03 ET4752.03
02:18 ET6812.005
02:32 ET32001.99
02:36 ET1401.9917
02:41 ET4952
02:43 ET1791.99
02:45 ET10001.9962
02:54 ET36002.0199
02:56 ET151002.0199
02:57 ET45992
03:03 ET5002.024
03:08 ET40002.0323
03:10 ET67632.0331
03:12 ET35002.0101
03:15 ET11872.03
03:17 ET7702.0127
03:24 ET65502.0764
03:26 ET40072.06
03:28 ET82992.0499
03:32 ET12002.0301
03:44 ET137892.06
03:46 ET61532.07
03:48 ET55782.08
03:50 ET61702.085
03:51 ET160602.12
03:53 ET103562.15
03:55 ET47632.14
03:57 ET140762.17
04:00 ET288942.2
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesINM
InMed Pharmaceuticals Inc
2.4M
-0.1x
---
United StatesBXRX
Baudax Bio Inc
1.7M
0.8x
---
United StatesSTAB
Statera Biopharma Inc
2.3M
0.0x
---
United StatesSNES
Senestech Inc
2.6M
-0.3x
---
United StatesMTP
Midatech Pharma PLC
2.9M
-0.1x
---
United StatesKLDO
Kaleido Biosciences Inc
8.5K
0.0x
---
As of 2023-02-05

Company Information

InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company that is engaged in the development, manufacturing and commercialization of rare cannabinoids. It is developing a pipeline of prescription-based products, including rare cannabinoids and novel cannabinoid analogs, targeting the treatment of diseases with unmet medical needs (Product Candidates). The Company’s segments include InMed Pharmaceuticals and BayMedica. The InMed Pharmaceuticals segment is engaged in research and development of cannabinoid-based pharmaceuticals products. The BayMedica segment is focused on developing manufacturing technologies to produce rare cannabinoids for sale in the health and wellness industry. Its two product candidates include INM-755 and INM-088. INM-755 is developed as a topical skin cream formulation containing cannabinol (CBN) for the treatment of symptoms related to Epidermolysis Bullosa (EB). INM-088 provides both neuroprotection and reduces intraocular pressure in the eye.

Contact Information

Headquarters
SUITE 310, 815 W. HASTINGS STREETVANCOUVER, BC, Canada V6C 1B4
Phone
604-669-7207
Fax
778-945-6800

Executives

Independent Chairman of the Board
William Garner
President, Chief Executive Officer, Director
Eric Adams
Interim Chief Financial Officer
Jonathan Tegge
Chief Operating Officer
Michael Woudenberg
Senior Vice President - Clinical and Regulatory Affairs
Alexandra Mancini

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.4M
Revenue (TTM)
$1.4M
Shares Outstanding
1.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.92
EPS
$-30.15
Book Value
$13.95
P/E Ratio
-0.1x
Price/Sales (TTM)
1.7
Price/Cash Flow (TTM)
---
Operating Margin
-1,265.81%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.